Literature DB >> 10203242

Ferrous iron modulates quinolinate-mediated [3H]MK-801 binding to rat brain synaptic membranes in the presence of glycine and spermidine.

F St'astny1, E Hinoi, K Ogita, Y Yoneda.   

Abstract

Quinolinic acid (QUIN) displaced binding of agonist and antagonist ligands for the N-methyl-D-aspartate (NMDA) receptor in rat brain synaptic membranes. Both QUIN and glutamic acid (GLU) potentiated binding of [3H]dizocilpine (MK-801) in the presence of glycine (GLY) alone, whereas the potentiation by QUIN was in a bell-shaped fashion in contrast to that by GLU. However, further addition of spermidine (SPD) induced bell-shaped potentiation by GLU as well as QUIN. The potentiation by QUIN was markedly deteriorated by the further addition of FeCl2 irrespective of the presence of GLY and SPD added. These results suggest that QUIN may potentiate [3H]MK-801 binding to the open NMDA channel in rat brain synaptic membranes through a mechanism different from that underlying the potentiation by GLU.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10203242     DOI: 10.1016/s0304-3940(99)00061-0

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  5 in total

1.  Involvement of glutamate neurotransmission in the development of excessive wheel running in Lewis rats.

Authors:  M Schwendt; R Duncko; A Makatsori; F Moncek; B B Johansson; D Jezova
Journal:  Neurochem Res       Date:  2003-04       Impact factor: 3.996

2.  Regulation of quinolinic acid neosynthesis in mouse, rat and human brain by iron and iron chelators in vitro.

Authors:  Erin K Stachowski; Robert Schwarcz
Journal:  J Neural Transm (Vienna)       Date:  2011-08-11       Impact factor: 3.575

Review 3.  Kynurenines in the mammalian brain: when physiology meets pathology.

Authors:  Robert Schwarcz; John P Bruno; Paul J Muchowski; Hui-Qiu Wu
Journal:  Nat Rev Neurosci       Date:  2012-07       Impact factor: 34.870

4.  Homocysteine-induced brain lipid peroxidation: effects of NMDA receptor blockade, antioxidant treatment, and nitric oxide synthase inhibition.

Authors:  Aurelio Jara-Prado; Alberto Ortega-Vazquez; Leticia Martinez-Ruano; Camilo Rios; Abel Santamaria
Journal:  Neurotox Res       Date:  2003       Impact factor: 3.911

Review 5.  Kynurenines in the Pathogenesis of Multiple Sclerosis: Therapeutic Perspectives.

Authors:  Tamás Biernacki; Dániel Sandi; Krisztina Bencsik; László Vécsei
Journal:  Cells       Date:  2020-06-26       Impact factor: 6.600

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.